PMC:7408073 / 71284-71569
Annnotations
LitCovid-PubTator
{"project":"LitCovid-PubTator","denotations":[{"id":"2601","span":{"begin":148,"end":155},"obj":"Chemical"},{"id":"2611","span":{"begin":32,"end":44},"obj":"Disease"}],"attributes":[{"id":"A2601","pred":"tao:has_database_id","subj":"2601","obj":"MESH:D002118"},{"id":"A2611","pred":"tao:has_database_id","subj":"2611","obj":"MESH:D006973"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"sidering that the prevalence of hypertension in Chinese adults is ~ 23% and that only about 41% take prescribed antihypertensive medications, being calcium channel blockers the most commonly used (~ 50%) in China [11]. To this regard, there is an interesting report describing sACE2 ac"}
LitCovid-PD-MONDO
{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T351","span":{"begin":32,"end":44},"obj":"Disease"}],"attributes":[{"id":"A351","pred":"mondo_id","subj":"T351","obj":"http://purl.obolibrary.org/obo/MONDO_0005044"}],"text":"sidering that the prevalence of hypertension in Chinese adults is ~ 23% and that only about 41% take prescribed antihypertensive medications, being calcium channel blockers the most commonly used (~ 50%) in China [11]. To this regard, there is an interesting report describing sACE2 ac"}
LitCovid-PD-CLO
{"project":"LitCovid-PD-CLO","denotations":[{"id":"T882","span":{"begin":92,"end":94},"obj":"http://purl.obolibrary.org/obo/CLO_0053794"},{"id":"T883","span":{"begin":214,"end":216},"obj":"http://purl.obolibrary.org/obo/CLO_0053733"}],"text":"sidering that the prevalence of hypertension in Chinese adults is ~ 23% and that only about 41% take prescribed antihypertensive medications, being calcium channel blockers the most commonly used (~ 50%) in China [11]. To this regard, there is an interesting report describing sACE2 ac"}
LitCovid-PD-CHEBI
{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T23518","span":{"begin":112,"end":128},"obj":"Chemical"},{"id":"T31593","span":{"begin":148,"end":172},"obj":"Chemical"},{"id":"T57795","span":{"begin":148,"end":155},"obj":"Chemical"}],"attributes":[{"id":"A73534","pred":"chebi_id","subj":"T23518","obj":"http://purl.obolibrary.org/obo/CHEBI_35674"},{"id":"A13092","pred":"chebi_id","subj":"T31593","obj":"http://purl.obolibrary.org/obo/CHEBI_38215"},{"id":"A92185","pred":"chebi_id","subj":"T57795","obj":"http://purl.obolibrary.org/obo/CHEBI_22984"},{"id":"A64826","pred":"chebi_id","subj":"T57795","obj":"http://purl.obolibrary.org/obo/CHEBI_29320"}],"text":"sidering that the prevalence of hypertension in Chinese adults is ~ 23% and that only about 41% take prescribed antihypertensive medications, being calcium channel blockers the most commonly used (~ 50%) in China [11]. To this regard, there is an interesting report describing sACE2 ac"}
LitCovid-PD-HP
{"project":"LitCovid-PD-HP","denotations":[{"id":"T110","span":{"begin":32,"end":44},"obj":"Phenotype"}],"attributes":[{"id":"A110","pred":"hp_id","subj":"T110","obj":"http://purl.obolibrary.org/obo/HP_0000822"}],"text":"sidering that the prevalence of hypertension in Chinese adults is ~ 23% and that only about 41% take prescribed antihypertensive medications, being calcium channel blockers the most commonly used (~ 50%) in China [11]. To this regard, there is an interesting report describing sACE2 ac"}
2_test
{"project":"2_test","denotations":[{"id":"32708755-29449338-20678906","span":{"begin":214,"end":216},"obj":"29449338"}],"text":"sidering that the prevalence of hypertension in Chinese adults is ~ 23% and that only about 41% take prescribed antihypertensive medications, being calcium channel blockers the most commonly used (~ 50%) in China [11]. To this regard, there is an interesting report describing sACE2 ac"}